Healthcare Innovations, 8
Back to All Secondary TrustsPortfolio Holdings by Security (As of Deposit Date)
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.34 |
AIMT | Aimmune Therapeutics, Inc. | 3.35 |
ANAB | AnaptysBio, Inc. | 3.35 |
APLS | Apellis Pharmaceuticals, Inc. | 3.32 |
ASND | Ascendis Pharma A/S | 3.30 |
ATNX | Athenex, Inc. | 3.33 |
BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.37 |
EBS | Emergent BioSolutions Inc. | 3.36 |
EIDX | Eidos Therapeutics, Inc. | 3.38 |
ENTA | Enanta Pharmaceuticals, Inc. | 3.31 |
EPZM | Epizyme, Inc. | 3.30 |
EXEL | Exelixis, Inc. | 3.31 |
GBT | Global Blood Therapeutics, Inc. | 3.34 |
GWPH | GW Pharmaceuticals plc | 3.39 |
HRTX | Heron Therapeutics, Inc. | 3.33 |
ICPT | Intercept Pharmaceuticals, Inc. | 3.29 |
IMMU | Immunomedics, Inc. | 3.33 |
INSM | Insmed Incorporated | 3.33 |
MDCO | The Medicines Company | 3.33 |
MDGL | Madrigal Pharmaceuticals, Inc. | 3.35 |
MRTX | Mirati Therapeutics, Inc. | 3.32 |
MYOK | MyoKardia, Inc. | 3.32 |
OPK | OPKO Health, Inc. | 3.33 |
PCRX | Pacira Pharmaceuticals, Inc. | 3.34 |
PTCT | PTC Therapeutics, Inc. | 3.33 |
QURE | uniQure N.V. | 3.31 |
RETA | Reata Pharmaceuticals, Inc. | 3.36 |
TBPH | Theravance Biopharma, Inc. | 3.30 |
TEVA | Teva Pharmaceutical Industries Ltd. | 3.35 |
XLRN | Acceleron Pharma Inc. | 3.33 |
Health Care
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.34 |
XLRN | Acceleron Pharma Inc. | 3.33 |
AIMT | Aimmune Therapeutics, Inc. | 3.35 |
ANAB | AnaptysBio, Inc. | 3.35 |
APLS | Apellis Pharmaceuticals, Inc. | 3.32 |
ASND | Ascendis Pharma A/S | 3.30 |
ATNX | Athenex, Inc. | 3.33 |
BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.37 |
EIDX | Eidos Therapeutics, Inc. | 3.38 |
EBS | Emergent BioSolutions Inc. | 3.36 |
ENTA | Enanta Pharmaceuticals, Inc. | 3.31 |
EPZM | Epizyme, Inc. | 3.30 |
EXEL | Exelixis, Inc. | 3.31 |
GBT | Global Blood Therapeutics, Inc. | 3.34 |
GWPH | GW Pharmaceuticals plc | 3.39 |
HRTX | Heron Therapeutics, Inc. | 3.33 |
IMMU | Immunomedics, Inc. | 3.33 |
INSM | Insmed Incorporated | 3.33 |
ICPT | Intercept Pharmaceuticals, Inc. | 3.29 |
MDGL | Madrigal Pharmaceuticals, Inc. | 3.35 |
MDCO | The Medicines Company | 3.33 |
MRTX | Mirati Therapeutics, Inc. | 3.32 |
MYOK | MyoKardia, Inc. | 3.32 |
OPK | OPKO Health, Inc. | 3.33 |
PCRX | Pacira Pharmaceuticals, Inc. | 3.34 |
PTCT | PTC Therapeutics, Inc. | 3.33 |
RETA | Reata Pharmaceuticals, Inc. | 3.36 |
TEVA | Teva Pharmaceutical Industries Ltd. | 3.35 |
TBPH | Theravance Biopharma, Inc. | 3.30 |
QURE | uniQure N.V. | 3.31 |
Summary
Description
-
Trust Name Healthcare Innovations, 8
-
Trust Symbol SMHCHX
-
MS Symbol STHC8
Deposit Data
-
Deposit Date 11/01/2019
-
Termination Date 20211102
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.0000
CUSIP
-
Cash Cusip 831704341
-
Reinvest Cusip 831704358
-
Fee Cash Cusip 831704366
-
Fee Invest Cusip 831704374
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.